Viruses are molecular machines sustained through a life cycle that requires replication within host cells. Throughout the infectious cycle, viral and cellular components interact to advance the multistep process required to produce progeny virions. Despite progress made in understanding the virus-host protein interactome, much remains to be discovered about the cellular factors that function during infection, especially those operating at terminal steps in replication. In an RNA interference screen, we identified the eukaryotic chaperonin T-complex protein-1 (TCP-1) ring complex (TRiC; also called CCT for chaperonin containing TCP-1) as a cellular factor required for late events in the replication of mammalian reovirus. We discovered that TRiC functions in reovirus replication through a mechanism that involves folding the viral σ 3 major outer-capsid protein into a form capable of assembling onto virus particles. TRiC also complexes with homologous capsid proteins of closely related viruses. Our data define a critical function for TRiC in the viral assembly process and raise the possibility that this mechanism is conserved in related non-enveloped viruses. These results also provide insight into TRiC protein substrates and establish a rationale for the development of small-molecule inhibitors of TRiC as potential antiviral therapeutics.
V iruses require cellular machinery to complete each step in a replication cycle. This machinery includes cell surface receptors that mediate attachment, endosomal and cytoskeletal proteins involved in viral entry and uncoating, and the translational apparatus required for viral protein synthesis. Although progress has been made in understanding host proteins required for early events in viral infection, much less is known about the cellular machinery used by viruses to accomplish later replication steps.
Mammalian orthoreoviruses (reoviruses) infect most mammals and have been implicated in coeliac disease pathogenesis in humans 1 . Reoviruses are non-enveloped and encapsidate a segmented, double-stranded RNA genome within a particle formed by an inner core and an outer capsid 2 . Reovirus enters the cell following attachment to membrane-bound receptors 3, 4 and clathrin-dependent endocytosis 5 , whereafter the particle is uncoated by cysteine proteases 6 , leading to delivery of the transcriptionally active core into the cytoplasm. In contrast to the well-characterized early infection steps, mechanisms governing genome assortment, assembly, transport and egress remain unclear. We conducted a two-step RNA interference (RNAi)-based screen to identify host proteins required for late steps in reovirus replication. Our screen uncovered three primary gene networks operating late in infection, including multiple components of the TRiC chaperonin.
TRiC is a ubiquitous, hetero-oligomeric complex formed by two eight-membered rings composed of paralogous subunits (CCT1-CCT8) 7 . These rings form a barrel-shaped structure with a central cavity that mediates ATP-dependent folding of newly translated proteins [8] [9] [10] . TRiC substrates often exhibit complex β -sheet topology, are aggregation prone and display slow folding kinetics 11 .
Many TRiC substrates also are subunits that form higher-order structures, such as actin and tubulin [12] [13] [14] . A potential role for TRiC may exist in the replication of eukaryotic viruses. Certain viral proteins interact with TRiC [15] [16] [17] , and gene-silencing studies suggest that TRiC is required for the replication of some viruses [18] [19] [20] . However, a mechanism for TRiC in viral protein folding or particle assembly has not been described.
Here, we show that TRiC is essential for reovirus replication. We discovered that TRiC forms a complex with the reovirus σ 3 outer-capsid protein and folds σ 3 into its native conformation. We also provide evidence that TRiC renders σ 3 into a conformation that can coalesce onto mature particles, which is a critical step in viral assembly. These findings elucidate a dynamic pathway for the efficient folding of viral capsid components mediated by the TRiC chaperonin.
Results

RNA interference screen for cellular mediators of late steps in reovirus replication identifies the TRiC chaperonin.
To identify host factors required for late steps in reovirus replication, we conducted a two-step RNAi-based screen to quantify reovirus replication after target gene knockdown (Fig. 1a ). Human brain microvascular endothelial cells (HBMECs) were transfected with a small interfering (si)RNA library containing 7,518 siRNA pools, each targeting an individual human gene (step 1). After incubation for 48 h, cells were infected with reovirus and incubated for an additional 48 h to allow replication and release of progeny. Supernatants were transferred to new plates containing fresh HBMECs (step 2), which were incubated for 24 h. Step 1 and step 2
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Reovirus μ2 siRNA Reovirus μNS NT Median robust Z-score (step 2 infectivity/step 1 infectivity) Fig. 1 | RNAi screen for cellular mediators of late steps in reovirus replication identifies the TRiC chaperonin. a, High-throughput screening schematic. b, Representative immunofluorescence images from reovirus-infected step 1 and step 2 cells transfected with an NT scrambled siRNA or reovirus-specific siRNAs (µ 2 or µ NS) and stained with DAPI (blue) and reovirus σ NS-specific antiserum (green). c, Venn diagram of the number of genes with robust Z-score < − 2.5 in each independent screen replicate. Overlapping regions indicate the number of genes with a robust Z-score < − 2.5 in multiple replicates. d, Top 20 candidate genes from the screen with Z-scores < − 2.5 in all three replicates. TRiC chaperonin genes (CCT) are highlighted in yellow. e, Median robust Z-scores from three independent screen replicates for individual target genes (black, n = 7,418), NT siRNA (green, n = 288), reovirus µ 2 siRNA (blue, n = 240) and CCT siRNAs (red).
NATuRe MICRObIOlOgy (Fig. 1b) . We hypothesized that any host factor required for a late step in viral infection would mirror the infectivity results observed with µ 2 and µ NS knockdown.
To identify candidate host genes, siRNA pools that compromised cell viability were excluded, and robust Z-scores for the siRNA library targets were calculated using step 1 and step 2 infectivity values. Negative robust Z-scores reflect diminished virus release. Seventy-four genes were at or below a predetermined robust Z-score threshold in each of the three independent screen replicates ( Fig. 1c ). STRING protein-protein interaction network analysis revealed an enrichment of Ras/MAPK, ubiquitin/proteasome and TRiC chaperonin gene networks ( Supplementary Fig. 1 ). The top 20 candidates included chaperone components, kinases and phosphatases, molecule transporters and various enzymes ( Fig. 1d ). Remarkably, six of the eight subunits of the TRiC chaperonin (CCT1, CCT2, CCT3, CCT4, CCT5 and CCT8) displayed median robust Z-scores less than − 2.5, implicating this host chaperonin in viral replication (Fig. 1e ).
The TRiC chaperonin is required for efficient reovirus replication, release and protein expression.
To validate the RNAi screen findings, we repeated the screening procedure using HBMECs transfected with pools of four TRiC-specific siRNAs different from those used in the screen. Infectivity in step 1 cells transfected with TRiC-specific siRNAs was within 15% of infectivity in NT siRNA controls ( Fig. 2a,b ). However, TRiC disruption significantly reduced step 2 cell infectivity compared with NT controls (Fig. 2a ,c). Thus, TRiC chaperonin knockdown decreases efficient release of infectious virus.
To determine the effect of TRiC disruption on reovirus replication, HBMECs were transfected with NT or TRiC-specific siRNAs and infected with reovirus. At 24 h post infection, reovirus titres were ~100-fold lower in cells transfected with CCT2-, CCT3-and CCT5-specific siRNAs compared with control cells (Fig. 2d ). At 48 h post infection, reovirus titres were ~100 to 1,000-fold lower in cells transfected with each TRiC-specific siRNA compared with control cells. Similar results were observed in experiments using human adenocarcinoma cells and human embryonic kidney cells ( Supplementary Fig. 2 ). Importantly, TRiC disruption did not alter cell viability ( Supplementary Fig. 3 ). Disruption of TRiC also did not affect the replication of chikungunya virus, an unrelated enveloped RNA virus that replicates in the cytoplasm 21 . Combined, these data indicate that TRiC function is required for efficient reovirus replication and that the requirement is not universal for all viruses.
To assess whether TRiC disruption alters reovirus protein expression, HBMECs were transfected with NT or TRiC-specific siRNAs and infected with reovirus. At 24 h post infection, cell lysates were prepared, resolved by SDS-PAGE and immunoblotted for reovirus proteins (Fig. 2f) or TRiC subunits and GAPDH ( Fig. 2g ). RNAi knockdown of each TRiC subunit substantially reduced the levels of intracellular reovirus proteins, providing evidence that TRiC is required for the production or stabilization of viral polypeptides.
TRiC redistributes to viral inclusions and is required for inclusion morphogenesis. Reovirus forms inclusions in infected cells
that serve as sites of progeny particle production 22 . To determine whether reovirus infection induces changes in the intracellular distribution of TRiC, we visualized TRiC in infected and uninfected cells by confocal and electron microscopy. The CCT1 and CCT3 TRiC subunits displayed a diffuse staining pattern in uninfected HBMECs (Supplemental Fig. 4 ). By contrast, their distribution was substantially altered in reovirus-infected cells, localizing primarily to viral inclusions ( Fig. 3a ). Electron microscopy of immunogoldlabelled TRiC revealed sparse, diffuse staining in uninfected cells and concentrated, inclusion-associated staining in infected cells (Fig. 3b ). These observations demonstrate that TRiC redistributes to sites of viral replication.
To determine the effect of TRiC disruption on viral inclusion morphogenesis, HBMECs were transfected with NT or TRiCspecific siRNAs, infected with reovirus and imaged by confocal and electron microscopy. In contrast to cells transfected with an NT siRNA, cells transfected with siRNAs targeting TRiC subunits exhibited distorted inclusion morphology ( Fig. 3c ). Instead of forming large globular structures, inclusions appeared as puncta or diffuse throughout the cytoplasm. Electron microscopy of reovirusinfected cells treated with an NT siRNA revealed electron-dense viral inclusions with numerous mature particles ( Supplementary  Fig. 4 ). In cells transfected with TRiC-specific siRNAs, viral inclusions appeared abnormal, and virions were occasionally distorted. Thus, the TRiC chaperonin is required for formation of viral inclusions and production of virions with normal morphology.
The TRiC chaperonin forms a complex with the reovirus σ3
outer-capsid protein. The TRiC chaperonin folds newly translated polypeptides through an ATP-dependent mechanism [8] [9] [10] . To determine whether TRiC folds 1 or more of the 11 viral proteins during infection, TRiC was immunoprecipitated from reovirus-infected HBMECs after metabolically labelling newly translated proteins with 35 S-methionine/cysteine. SDS-PAGE of the input protein identified reovirus-specific large (λ ), medium (µ ) and small (σ ) polypeptides in infected cells ( Fig. 4a , left). SDS− PAGE of immunoprecipitated TRiC revealed known TRiC binding partners (actin and tubulin 23 ) and an additional virus-specific band migrating at ~40 kDa ( Fig. 4a , right). To confirm this interaction, TRiC was immunoprecipitated from reovirus-infected HBMECs, and co-immunoprecipitating proteins were resolved by SDS-PAGE and immunoblotted for reovirus proteins. The same viral protein at ~40 kDa co-immunoprecipitated with the TRiC chaperonin ( Supplementary Fig. 5 ). Using proteinspecific monoclonal antibodies, the 40 kDa band was identified as σ 3 (Fig. 4b, lane 4) . Reovirus σ 3 is an essential structural component that complexes with the viral µ 1 protein to form µ 1 3 σ 3 3 heterohexamers. These heterohexamers coalesce onto assembling virions to form the outer capsid 24, 25 . The identification of an intracellular TRiC-σ 3 complex led us to hypothesize that TRiC functions in reovirus replication by folding σ 3 into its native state or contributing to its assembly into higher order structures.
To determine whether reovirus σ 3 is a TRiC substrate, σ 3 was translated in rabbit reticulocyte lysates (RRLs) in the presence of 35 S-methionine (met), resolved by native PAGE and visualized by phosphorimaging. RRLs are rich in chaperones, including TRiC, and have been used to identify putative TRiC substrates 26, 27 . In addition to σ 3, human β -actin (a TRiC substrate 13, 28 ) and green-fluorescent protein (GFP) (folds independently of TRiC 27 ) were translated as controls. GFP migrated as a low molecular weight monomer over the intervals of translation (Fig. 4c, lanes 1-3) . β -Actin migrated in two primary forms: a low molecular weight monomer and a high molecular weight ~800 kDa species corresponding to a TRiC-actin complex (Fig. 4c , lanes 4-6). In vitro translated σ 3 from two prototype reovirus strains (T1L and T3D) migrated almost exclusively as a high molecular weight species (Fig. 4c , lanes 7-12). A free σ 3 monomer did not accumulate over time, suggesting that in vitro translated σ 3 remains bound to TRiC in a stable complex. To determine whether structurally-related viral outer-capsid proteins form a complex with TRiC, American grass carp aquareovirus (GCRV) VP7 and Colorado tick fever virus (CTFV, a coltivirus) VP11 were translated in RRLs. GCRV VP7 and CTFV VP11 migrated primarily as high molecular weight complexes by native PAGE, as was observed with σ 3 (Fig. 4d ). Therefore, homologous capsid proteins of Reoviridae members form a complex with the TRiC chaperonin.
For certain substrates, TRiC functions as a holdase, retaining the polypeptide in a quasi-native state until an interaction with a binding partner or co-chaperone mediates a final folding or release event 29, 30 . To assess the stability of the complex formed between σ 3
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and TRiC, σ 3 was translated in the presence of 35 S-met for 5 minutes, incubated with cold met for 4 h, and resolved by native ( Fig. 4e ) and SDS-PAGE ( Supplementary Fig. 5 ). Newly translated β -actin migrated in both TRiC-bound and TRiC-free forms (Fig. 4e, lane 3) . After a 4 h chase, the high molecular weight TRiC-actin complex decreased in abundance with a corresponding increase in free, monomeric β -actin (Fig. 4e, lane 4) . By contrast, in vitro translated σ 3 remained TRiC-bound throughout the duration of the cold met chase (Fig. 4e , lanes [5] [6] [7] [8] . These data indicate that the complex formed between TRiC and σ 3 is stable long after translation has completed, suggesting that TRiC functions as a holdase for σ 3.
To confirm that the high molecular weight species in the in vitro translation reactions corresponds to TRiC-bound substrate, σ 3 was translated in TRiC-immunodepleted RRLs and resolved by native NATuRe MICRObIOlOgy PAGE ( Fig. 4f ). TRiC was reproducibly immunodepleted to levels 80-85% less than that of mock-depleted RRLs ( Supplementary  Fig. 5 ). The ~800 kDa form of σ 3 was substantially reduced in TRiC-depleted RRLs (Fig. 4f, lane 4 ). In addition, σ 3 translated in TRiC-depleted RRLs accumulated in a high molecular weight form that did not enter the native gel, indicative of protein aggregation (Fig. 4f , lane 4, asterisk). Reconstitution of immunodepleted RRLs with purified human TRiC (hTRiC) restored the intensity of the ~800 kDa band (Fig. 4f , lane 5), providing evidence that the high molecular weight species constitutes a stable TRiC-σ 3 complex. Since TRiC forms a complex with σ 3, we hypothesized that the defects in viral protein production ( Fig. 2f ) and viral inclusion formation ( Fig. 3c ) with TRiC disruption are attributable to a failure in σ 3 biogenesis. We tested whether siRNA disruption of σ 3 mirrored the effect of TRiC disruption on viral inclusion formation. RNAi knockdown of σ 3 in reovirus-infected cells resulted in decreased viral protein expression and distorted viral inclusions that failed to mature into large globular structures ( Supplementary Fig. 6 ), mimicking results observed with TRiC knockdown. We conclude that the observed effects of TRiC disruption on viral protein synthesis and inclusion morphology are a result of defects in σ 3 production.
The intracellular biogenesis of native σ3 conformers requires the TRiC chaperonin.
To determine whether TRiC is required to fold σ 3 within infected cells, HBMECs expressing CCT2 or CCT5 short hairpin (sh)RNAs were infected with reovirus, and intracellular σ 3 was visualized by confocal microscopy. Folded σ 3 was detected using a conformation-sensitive monoclonal antibody specific for the native form of the protein 31 . TRiC disruption substantially reduced the forms of σ 3 recognized by the conformation-specific antibody, whereas infected cells with intact TRiC produced abundant folded σ 3 (Fig. 5a ). To assess total levels of σ 3, cells were 
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stained with a σ 3-specific polyclonal antiserum capable of recognizing folded and unfolded epitopes. Total σ 3 immunofluorescence (folded and unfolded) was substantially greater than folded σ 3 in TRiC-deficient cells (Fig. 5b ). The average σ 3 staining area ( Fig. 5c ) and intensity ( Fig. 5d ) were significantly higher for total σ 3 relative to folded σ 3. Despite the increased levels of total σ 3 observed by confocal microscopy, the total amount of full-length, soluble σ 3 detectable by immunoblotting was substantially reduced in TRiCdeficient cells (Fig. 5e, lanes 7-12) . Therefore, TRiC disruption results in accumulation of σ 3 conformers that are partially translated, proteolytically cleaved or aggregated and insoluble.
To determine the effect of TRiC disruption on the production of native intracellular σ 3, HEK-293T cells were transfected with an NT or TRiC-specific siRNA and transfected with expression plasmids or infected with reovirus ( Fig. 5f ). Cell lysates were resolved by native PAGE and immunoblotted for σ 3 (Fig. 5g ) or TRiC ( Supplementary Fig. 7 ). Expression of all proteins was confirmed by SDS-PAGE ( Fig. 5h ). When expressed alone, σ 3 migrated in two predominant forms: a low molecular weight complex at ~140 kDa, corresponding to a σ 3 homo-oligomer 32, 33 , and a high molecular weight complex at ~800 kDa, corresponding to the TRiC-bound form of σ 3 (Fig. 5g, lane 2) . When co-expressed with its outer-capsid binding partner, µ 1, σ 3 migrated primarily at a molecular weight of ~400 kDa (Fig. 5g, lane 3) , corresponding to the assembled µ 1 3 σ 3 3 heterohexamer 34 . In reovirus-infected cells, the forms of intracellular σ 3 included the TRiC-bound species, µ 1 3 σ 3 3 heterohexamer, and σ 3 homo-oligomer, as well as an unknown band migrating at ~250 kDa (Fig. 5g, lane 4) . RNAi disruption of TRiC resulted in a striking perturbation of the intracellular forms of σ 3. When expressed alone in TRiC-disrupted cells, σ 3 migrated as a single, low-intensity, high molecular weight band corresponding to a complex with residual intracellular TRiC (Fig. 5g, lane 6) . When co-expressed with µ 1 
in TRiC-disrupted cells, σ 3 exclusively migrated as a faint band at ~400 kDa (Fig. 5g, lane 7) . Finally, native intracellular σ 3 was virtually undetectable in reovirus-infected, TRiC-disrupted cells (Fig. 5g , lane 8). Importantly, overall levels of de novo translation were not affected by TRiC disruption, as GFP expression was equivalent in cells treated with NT or TRiC-specific siRNAs (Fig. 5h, lane 1,5 ). These data indicate that TRiC is required for the intracellular production of the multiple native forms σ 3. 
The TRiC chaperonin folds σ3 into a native, assembly-competent conformation. To determine whether TRiC directly folds σ 3 into its native conformation, σ 3 was translated in mock-or TRiCdepleted RRLs (Fig. 6a ). Translated σ 3 was immunoprecipitated using a conformation-specific antibody and resolved by SDS-PAGE ( Fig. 6a, i) . Reovirus σ 3 was efficiently immunoprecipitated from mock-depleted RRLs (Fig. 6b, lane 3) . By contrast, there was a 67% reduction in the amount of σ 3 immunoprecipitated from TRiC-depleted reactions (Fig. 6b, lane 6) . Immunoprecipation of σ 3 translated in TRiC-depleted RRLs reconstituted with hTRiC yielded levels similar to mock-depleted RRLs (Fig. 6b, lane 9 , quantified in Supplementary Fig. 8 ). To identify the σ 3 species recognized by the conformation-specific antibody, we resolved the immunoprecipitation flow-through containing unbound protein by native PAGE (Supplementary Fig. 8 ). The σ 3-specific antibody depleted the ~800 kDa form of σ 3 from translation reactions, revealing that the antibody recognizes an exposed region of σ 3 bound to TRiC. These results provide evidence that TRiC directly folds and retains σ 3 in an exposed conformation capable of interacting with binding partners.
To further test whether TRiC directly folds σ 3, we quantified the protease sensitivity of σ 3 translated in mock-or TRiC-depleted RRLs (Fig. 6a, ii) . Unfolded proteins often exhibit increased protease sensitivity because of the exposure of additional cleavage sites 35, 36 . Reovirus σ 3 was translated in mock-or TRiC-depleted RRLs, digested with proteinase K for various intervals and resolved by SDS-PAGE. Compared with mock-depleted RRLs, σ 3 translated in TRiC-depleted RRLs displayed enhanced proteinase K sensitivity ( Fig. 6c, Supplementary Fig. 8 ). Reconstitution of depleted RRLs with purified hTRiC decreased the sensitivity of translated σ 3 to protease digestion, providing further evidence that TRiC folds σ 3 into its native conformation.
To determine whether TRiC renders σ 3 into a conformation capable of assembly, we tested whether reovirus infectious subvirion particles (ISVPs) could be recoated with σ 3 translated in RRLs. (Fig. 6a, iii) . ISVPs are naturally occurring reovirus disassembly intermediates formed during cell entry. These particles lack σ 3 and contain a cleaved form of the σ 3-binding partner, μ 1 (μ 1δ ) ( Fig. 6d ). ISVPs can be recoated with purified σ 3 to produce the mature outer capsid 37 . We translated σ 3 in mock or TRiC-depleted RRLs (Fig. 6e ), incubated reactions with ISVPs and immunoprecipitated recoated particles with a μ 1δ -specific antibody. We confirmed that this antibody recognizes μ 1δ and not σ 3 ( Supplementary Fig. 8 ). TRiC depletion resulted in a 92% reduction in the efficiency of ISVP recoating (Fig. 6e , lane 6, quantified in Supplementary Fig. 8 ). Concordantly, reconstitution of RRLs with purified hTRiC restored recoating activity (Fig. 6e, lanes 9 and 12) . Thus, TRiC folds σ 3 into a conformation capable of recoating ISVPs, providing evidence that TRiC functions in viral particle assembly by folding the σ 3 outercapsid protein.
Discussion
In this study, we used an RNAi-based screen to identify cellular factors required for late steps in reovirus infection and discovered that the TRiC chaperonin mediates reovirus capsid protein folding. Found within all eukaryotic cells, TRiC interacts with 5-10% of cytoplasmic proteins and exhibits substrate specificity, although no consensus TRiC-binding determinants have been identified 11 . Our data support a model in which TRiC binds and folds reovirus σ 3 into its native conformation, after which the folded protein is retained within TRiC, released as a stable homo-oligomer or incorporated into the µ 1 3 σ 3 3 heterohexamer for assembly onto progeny virions (Fig. 6f) . These observations enhance an understanding of the cell biology of reovirus infection and yield a new function for the TRiC chaperonin.
Presently no rules or patterns have been defined for viral substrates of the TRiC chaperonin. In certain cases, such as with reovirus σ 3, retroviral Gag 15, 38 and the hepatitis B virus core protein 16 , TRiC appears to fold capsid components, potentially directing their assembly into mature particles. For other viruses, TRiC interacts with less abundant non-structural proteins, such as Epstein-Barr virus EBNA-3 17 and hepatitis C virus NS5B 18 . In the case of capsid components, the requirement for TRiC-mediated folding might be due to the propensity of these proteins to rapidly misfold and form insoluble aggregates. As for viral non-structural proteins, the presence of multiple domains with independent folding requirements may dictate the need for TRiC. Why certain viruses require TRiC and others do not, and whether viral substrates of TRiC can be predicted, remain key unanswered questions.
Although we provide evidence that TRiC folds σ 3, we do not understand the biochemical features that render σ 3 an obligate TRiC substrate. A complex between TRiC and σ 3 may form during translation to prevent nascent chain misfolding. Alternatively, σ 3 may be refractory to spontaneous folding after release from ribosomes, requiring the exploration of various intermediates before achieving a native conformation. The structure of σ 3 contains β -sheets that form via long-range intramolecular interactions 32 , and these secondary structures may not form spontaneously, requiring the iterative cycling of TRiC to complete the folding process. The σ 3 protein also harbours a hydrophobic amino-terminal domain that forms the binding interface between homo-oligomers and molecules of µ 1 in the µ 1 3 σ 3 3 heterohexamer. This domain is likely to be insoluble and aggregation prone in the aqueous cytoplasm, and TRiC, like other chaperonins 39 , may function to provide a thermodynamically favourable environment to allow the domain to fold. The combined effect of TRiC co-translational binding and iterative folding may be necessary for the efficient folding and assembly of σ 3 onto new virus particles.
After folding, TRiC substrates are usually released from the interior chamber and exit into the cytosol. However, for certain substrates, such as the Von Hippel-Lindau (VHL) protein, release is more complex. After an initial folding event, TRiC functions as a holdase for VHL, retaining the protein in a quasi-native conformation competent for assembly into higher-order structures 29 . The complete folding and release of VHL occurs only after interaction with elongin-BC, the VHL binding-partner 29 . Our observation that σ 3 translated in RRLs forms a stable complex with TRiC ( Fig. 4d ) suggests that TRiC functions as a σ 3 holdase, stabilizing σ 3 in a form primed for assembly. Through its holdase activity, TRiC could sequester aggregation-prone domains of σ 3, such as the hydrophobic amino terminus, and maintain the protein in a conformation competent for assembly into homo-oligomers or heterohexamers. Owing to similarities in the replication cycles of Reoviridae viruses, we predict that this TRiC-mediated folding mechanism operates broadly to stabilize and assemble aggregation-prone viral capsid components.
Despite its observed holdase function, TRiC must liberate native σ 3 for virus assembly. An interaction between TRiC-bound σ 3 and nascent µ 1 could trigger σ 3 release. Alternatively, an unknown host co-chaperone could facilitate the productive release of native σ 3 from TRiC. There is precedent for such a mechanism, as certain substrate-specific co-chaperones function following the action of TRiC to aid in the folding and assembly of oligomers. The α /β tubulin co-chaperones function following TRiC to assemble microtubules 40 , and phosducins participate in the assembly of the G-protein β γ dimer after TRiC-mediated β -subunit folding 41 . In the case of reovirus σ 3, assembly into a complex with a host or viral protein is likely required for the release of the native protein following TRiC-mediated folding.
The different subunits in hetero-oligomeric TRiC have distinct binding specificities 38 and, thus, substrate selection results from the combinatorial recognition of unique binding determinants in a substrate 42, 43 . These binding determinants may associate with TRiC
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as helical structures, such as in a 54 amino acid stretch in the p6 domain of HIV Gag 15, 38 , or in an extended state, as in a 6-9 amino acid sequence in Box 1 of VHL 7, 44 . Our finding that outer-capsid proteins of mammalian orthoreovirus (σ 3), aquareovirus (VP7), and coltivirus (VP11) bind to TRiC suggests that certain shared biochemical features facilitate chaperonin binding. These viral 
capsid proteins exhibit less than 20% amino acid identity but show similar hydrophobicity profiles in certain sequence regions 45 . These conserved hydrophobic regions may dictate TRiC binding and constitute a shared substrate motif, which supports a potential new determinant of TRiC binding. Our results establish a function for the TRiC chaperonin in the folding of a non-enveloped virus capsid component. The broad conservation of TRiC in eukaryotes and the common principles of assembly of non-enveloped viruses raise the possibility that TRiC folds capsid components of other viruses. Findings reported here establish a foundation to better understand the rules governing TRiC substrate selection and set the stage for development of TRiC inhibitors as potentially broad-spectrum antiviral therapeutics.
Methods
Cells and viruses. HBMECs were provided by Kwang Sik Kim 46 (Johns Hopkins
University) and cultured in RPMI 1640 medium as described. U-2 osteosarcoma (OS) (ATCC HTB-96) cells were maintained in McCoy's 5A medium supplemented to contain 10% fetal bovine serum (FBS). HEK-293T (ATCC CRL-3216) cells were maintained in DMEM supplemented to contain 10% FBS and 1% sodium pyruvate. Caco-2 cells (ATCC HTB-37) were maintained in DMEM supplemented to contain 10% FBS, 1% non-essential amino acids and 1% sodium pyruvate. Spinner-adapted murine L929 fibroblast cells were grown in either suspension or monolayer cultures as described 47 . Viral titres were determined by plaque assay using L929 cells as described 48 . Cell viability was quantified by PrestoBlue assay (Thermo Fisher, A13261) according the manufacturer's instructions. HBMECs were tested for mycoplasma contamination using the Venor GeM mycoplasma detection kit (Sigma, MP0025). No authentication was performed on the cell lines used in this study.
Reovirus strains T1L and T3D were recovered using plasmid-based reverse genetics 49 and purified as described 50 . Reovirus T1L M1 P208S, which harbours a point mutation in the M1 gene allowing it to form globular, T3D-like inclusions 51 , was used in the RNAi screen to facilitate visualization of reovirus-infected cells by high-throughput automated microscopy. The chikungunya virus 181/25 infectious clone plasmid was generated as described 52 . To engineer plasmids for transient transfection and in vitro translation studies, open reading frames were amplified by PCR using primers containing 5′ KpnI and 3′ NotI restriction sites (Supplementary table 2 ). PCR fragments were purified, digested and ligated into the corresponding KpnI/NotI restrictions sites in the pcDNA3.1+ vector. The following templates were used for PCR amplification: human β -actin (DNASU, HsCD00042977), American grass carp reovirus VP7 (GeneScript, Gene ID: 6218809), Colorado tick fever virus VP11 (GeneScript, Gene ID: 993319), peGFP-N1 (Addgene, 6085-1), pT7-T1L S4 (σ 3) (Addgene, 33295), pT7-T3D S4 (σ 3) (Addgene, 33285), pT7-T1L M2 (µ 1) (Addgene, 33290).
To propagate shRNA-encoding lentiviruses, 1 × 10 7 HEK-293T cells were cotransfected with 0.6 µ g pVSVG, 3 µ g pCMV Lenti 8.92 Gag/Pol and 6 µ g of an empty shRNA control (Sigma, SHC201), CCT2-specific shRNA (Sigma, SHCLNG-NM_006431) or CCT5-specific shRNA (Sigma, SHCLNG-NM_012073) using the FuGene 6 transfection reagent. The culture medium was replaced 24 h post transfection with complete RPMI medium, and cells were incubated at 37 °C for 48 h. The medium containing packaged lentiviral particles was clarified by centrifugation at 4,000g at 4 °C for 10 min and stored at − 80 °C. For lentiviral transduction, 3 ml of lentivirus-containing cell culture medium was combined with 3 µ l of polybrene (Millipore, TR-1003-G), vortexed briefly, incubated at room temperature for 5 min and added to HBMECs. After incubation overnight, the culture medium was supplemented to contain 1 µ g ml −1 puromycin. Target knockdown was confirmed by immunoblotting.
In vitro transcription, translation and 35 S-metabolic labelling.
Coupled in vitro transcription and translation reactions were conducted using the TNT coupled rabbit reticulocyte lysate system (Promega, L4610) according to the manufacturer's instructions. Using pcDNA3.1+ templates for in vitro transcription and translation, reactions were incubated at 30 °C for variable intervals depending on the experimental conditions. Reactions were supplemented with [ 35 S]-methionine (Perkin Elmer, NEG709A500UC) for radiolabelling and RNasin Plus RNase Inhibitor (N2611). Where indicated, reactions were chased with cold methionine added to a final concentration of 2 mM. Translation reactions were terminated by fourfold dilution in stop buffer (20 mM HEPES-KOH pH 7.4, 100 mM potassium acetate, 5 mM magnesium acetate, 5 mM EDTA, 2 mM methionine) supplemented with a final concentration of 1 mM dithiothreitol (DTT) and 2 mM puromycin. Samples were used for immunoprecipitation, ISVP recoating, proteinase K (Sigma, P4850) digestion (final concentration of 2.5 µ g ml −1 ), or resolved by native and SDS-PAGE.
For metabolic labelling of de novo protein synthesis in cells, 4 × 10 6 HBMECs were infected with reovirus for 20 h. Cells were incubated in methionine/cysteinefree medium for 20 min, labelled with medium supplemented with 35 S-methionine and cysteine (0.4 mCi ml −1 ) (Perkin Elmer, NEG772007MC) for 5 min and chased with medium supplemented with 50 mM cold methionine and cysteine for 1 min. Radiolabelled TRiC-bound proteins were isolated by immunoprecipitation and visualized by SDS-PAGE.
Native cell lysis, immunoprecipitations and immunodepletions. Native HEK-293T cell lysates were prepared by suspending cells in ice-cold ATP depletion buffer (1 mM sodium azide, 2 mM 2-deoxyglucose, 5 mM EDTA and 5 mM cycloheximide in phosphate-buffered saline without calcium and magnesium (PBS− /− )), followed by centrifugation at 300g at 4 °C for 5 min. Cells were resuspended in lysis buffer A (50 mM HEPES pH 7.4, 100 mM KCl, 1.5 mM MgCl 2 , 0.5% NP-40) supplemented to contain 2 mM phenylmethylsulfonyl fluoride (PMSF, Sigma, P7626), protease inhibitor cocktail (Sigma, P8340) and benzoase (Sigma, E1014) and incubated on ice for 10 min. Lysates were clarified by centrifugation at 20,000g at 4 °C for 10 min, and the protein concentration was quantified using a DC protein assay (BioRad, 5000112). DTT was added to each sample to a final concentration of 1 mM, and equal amounts of protein sample were diluted in 4 × Native PAGE Sample Buffer and Native PAGE G-250 Sample Additive (0.125% final concentration, Thermo Fisher, BN2004).
To immunoprecipitate TRiC from reovirus-infected cells, HBMECs were harvested in ice-cold ATP-depletion buffer and collected by centrifugation at 300g at 4 °C for 5 min. Cells were resuspended in lysis buffer B (50 mM HEPES-KOH pH 7.5, 100 mM KCl, 5 mM EDTA, 10% glycerol) supplemented with protease inhibitor cocktail and lysed by dounce homogenization (70 strokes). Lysates were clarified by centrifugation at 20,000g at 4 °C for 10 min. Clarified cell lysates were combined with 2 µ g of a rabbit CCT2-specific monoclonal antibody (Abcam, ab92746) or an immunoglobulin (Ig)G isotype control antibody (Abcam, ab172730) and incubated at 4 °C for 30 min with rotation. Cell lysates were combined with Protein G Dynabeads (Thermo Fisher, 10004D) and incubated at 4 °C for 30 min with rotation. Bead-bound antibody-antigen complexes were washed four times with ice-cold TRiC wash buffer (50 mM HEPES-KOH pH 7.5, 100 mM KCl, 5 mM EDTA, 10% glycerol, 0.05% NP-40), eluted with SDS sample buffer and resolved by SDS-PAGE.
To immunoprecipitate proteins translated in vitro in RRLs, 5 µ g of mouse 10C1 σ 3 monoclonal antibody (for σ 3 immunoprecipitations), mouse 8H6 µ 1/µ 1δ monoclonal antibody (for recoated ISVP immunoprecipitations) or IgG isotype control antibody (mouse 2F5 σ NS monoclonal antibody 53 ) were incubated with reactions at 4 °C for 1 h with rotation. Samples were added to Protein G Dynabeads and incubated at 4 °C for 1 h with rotation. The flow-through containing unbound protein was resolved by native PAGE. Dynabeads were washed four times with Tris-buffered saline (20 mM Tris-HCl pH 7.5, 150 mM NaCl) containing 0.1% Tween-20, eluted with SDS sample buffer and resolved by SDS-PAGE.
TRiC was immunodepleted from RRLs by incubating 75 µ l of RRLs with 8 µ g of a rabbit CCT2-specific polyclonal antiserum 27 or an equivalent volume of resin wash buffer (10 mM Tris-HCl pH 7.5, 25 mM KCl, 0.5 mM magnesium acetate) and incubated at 4 °C for 2 h with rotation. Protein A-agarose fast flow resin (Sigma, P3476) was pre-washed four times with 1 ml of resin wash buffer. RRLs were incubated with protein A beads at 4 °C for 2 h, and bead-bound antibody/ TRiC complexes were collected by centrifugation at 2,000g at 4 °C for 5 min. This process was repeated twice with the supernatant to further deplete TRiC. Where indicated, RRLs were reconstituted with recombinant human TRiC (provided by the Frydman laboratory, Stanford University).
Native and SDS-PAGE, immunoblotting, phosphorimaging. Native PAGE. Samples for native PAGE were diluted in 4 × Native PAGE Sample Buffer (Thermo Fisher, BN2003) and loaded into wells of 4-16% Native PAGE Bis-Tris acrylamide gels (Thermo Fisher). Samples were electrophoresed using the blue native PAGE Novex Bis-Tris gel system (Thermo Fisher) at 150 V at 4 °C for 60 min, followed by 250 V at 4 °C for 40 min. Light blue anode buffer was supplemented with 0.1% L-cysteine and 1 mM ATP. Following electrophoresis, gels were incubated in 40% methanol, 10% acetic acid at RT for 1 h, washed three times with ddH 2 O, and dried on filter paper at 80 °C for 2 h using a BioRad model 583 gel dyer. Dried gels were exposed on a phosphorimaging screen for 12-36 h and imaged using a Perkin Elmer Cyclone Phosphor System Scanner (B431200). Protein bands labelled with 35 S-met were analysed using ImageJ software 54 . To immunoblot native cell lysates, samples were resolved by blue native PAGE with the following modification: DTT was added to the light blue cathode buffer to a final concentration of 1 mM. Following electrophoresis, proteins were transferred to a polyvinylidene difluoride (PVDF) membrane (BioRad, 162-0177) at 25 V at 4 °C for 2 h. Following NATuRe MICRObIOlOgy transfer, the membrane was soaked in 8% acetic acid for 15 min, rinsed with ddH 2 O, and dried. The membrane was incubated with 100% methanol for 1 min, rinsed with ddH 2 O, blocked with 5% bovine serum albumin (BSA) diluted in PBS− /− , and incubated with antibodies for immunoblotting. All native gels were electrophoresed with the NativeMark Protein Standard (ThermoFisher, LC0725) for molecular weight estimation.
SDS-PAGE.
Samples for denaturing PAGE were diluted in 5× SDS-PAGE sample buffer and incubated at 95 °C for 10 min. Samples were loaded into wells of 10% acrylamide gels (BioRad, 4561036) and electrophoresed at 100 V for 90 min. Follow electrophoresis, gels were either stained with colloidal blue (ThermoFisher, LC6025) or transferred to nitrocellulose for immunoblotting. Immunoblots were scanned using an Odyssey CLx imaging system (Li-Cor) and analyzed as described 55 .
The following antibodies were used for immunoblotting: guinea pig σ NS polyclonal antiserum 56 , rabbit reovirus-specific polyclonal antiserum 57 , mouse 4F2 σ 3 monoclonal antibody 31 , rabbit VU219 σ 3 polyclonal antiserum (this study), mouse 8H6 µ 1/µ 1δ monoclonal antibody 31 , rat CCT1 monoclonal antibody (Enzo Life Sciences, ADI-CTA-123), rabbit CCT2 monoclonal antibody (Abcam, ab92746), rabbit CCT3 polyclonal antiserum (ABclonal, A6547), mouse CCT4 monoclonal antibody (Santa Cruz, sc-137092), rabbit CCT5 monoclonal antibody (Abcam, ab129016), mouse CCT8 polyclonal antibody (Novus Biologicals, H00010694-B02P), mouse GAPDH monoclonal antibody (Sigma, G8795) and rabbit GFP polyclonal antiserum (Santa-Cruz, sc-8334).
Immunofluorescence microscopy, image analysis and quantification. Confocal microscopy was performed as described 47 with the following modifications: cells were fixed in 4% paraformaldehyde (PFA, Electron Microscopy Sciences, 15712-s) diluted in PBS− /− at RT for 20 min and counterstained with 4′ ,6-diamidino-2phenylindole (DAPI, Invitrogen, D3571) to label nuclei. Confocal images were captured using a Zeiss LSM 710 laser scanning confocal microscope equipped with a 63× oil objective. Images were processed using Zen 2012 and ImageJ software with the Fiji plugin 54 . Immunofluorescence images to quantify folded and unfolded reovirus σ 3 were captured using a Lionheart FX automated microscope (BioTek) equipped with a 20× air objective. Images were processed and signals quantified using Gen5+ software (BioTek). The following antibodies were used: guinea pig σ NS polyclonal antiserum 56 , mouse 10C1 σ 3 monoclonal antibody (conformationspecific antibody, used to label native σ 3 (ref. 31 ), rabbit VU219 σ 3 polyclonal antiserum (used to label total σ 3), rabbit anti-CCT1 polyclonal antiserum (NeoScientific, A1950), rabbit CCT3 polyclonal antiserum (ABclonal, A6547).
ISVP purification and recoating. To generate ISVPs, 2 × 10 12 purified T1L reovirus particles were incubated with chymotrypsin (Sigma, C3142) diluted to 200 µ g ml −1 at 37 °C for 60 min. Digestion was terminated by the addition of PMSF to a final concentration of 2 mM. ISVPs were purified by caesium chloride gradient (1.25 g ml −1 to 1.45 g ml −1 ) centrifugation with a Beckman Coulter Optima L-90K ultracentrifuge and SW-41 rotor at 25,000 rpm at 5 °C overnight. Purified ISVPs were dialysed in four 1 l volumes of virion storage buffer (10 mM Tris-HCl pH 7.5, 150 mM KCl, 15 mM MgCl 2 ) and stored at 4 °C. Virion-to-ISVP conversion was confirmed by SDS-PAGE and colloidal blue staining to assess the loss of σ 3 and cleavage of µ 1C to µ 1δ . For recoating experiments, ISVPs (5 × 10 10 ) or an equal volume of virion storage buffer were added to in vitro translated σ 3 and incubated at 37 °C for 2 h. Electron microscopy. Cells were incubated with a mixture of 4% PFA and 1% glutaraldehyde in 0.4 M HEPES buffer, pH 7.4 at room temperature for 1 h. Cells were incubated with 1% osmium tetroxide and 0.8% potassium ferricyanide in water at 4 °C for 1 h and dehydrated in 5 minute steps with increasing concentrations of acetone (50%, 70%, 90% and twice in 100%) at 4 °C. Samples were incubated at room temperature overnight with a 1:1 mixture of acetoneresin, infiltrated for 8 h in pure epoxy resin EML-812 (TAAB Laboratories) 22 and polymerized at 60 °C for 48 h. Ultrathin (~60 nm) oriented serial sections were prepared using a UC6 ultramicrotome (Leica Microsystems), collected on uncoated 300-mesh copper grids (TAAB Laboratories), stained with saturated uranyl acetate and lead citrate, and imaged by transmission electron microscopy (TEM). Images were acquired using a JEOL JEM 1011 electron microscope operating at 100 kv. Reovirus inclusion and particle morphology were assessed by imaging more than 100 HBMECs reverse-transfected with non-targeting (luciferase siRNA) or TRiC subunit-specific siRNAs by TEM.
For immunogold labelling on thawed cryosections (Tokuyasu method 58, 59 ),cells were incubated with 4% PFA in PHEM buffer, pH 7.2 (60 mM piperazine-N,N′ -bis (2-ethanesulfonic acid), 25 mM HEPES, 10 mM EGTA, 2 mM MgCl 2 ) at RT for 2 h, followed by 50 mM NH 4 Cl to quench free aldehydes groups. Cells were collected by centrifugation, embedded in 12% gelatin (TAAB Laboratories) in PBS, and incubated on ice for 15 min. Pellets were divided into 1 mm 3 cubes and incubated at 4 °C overnight with 2.1 M sucrose in PBS. Blocks were mounted on metal pins and frozen in liquid nitrogen. Ultrathin cryosections (50-100 nm) were prepared using a diamond knife and a UC6 cryoultramicrotome (Leica Microsystems) operating at − 120 °C. Sections were collected using a mixture of 2% methylcellulose in H 2 O and 2.1 M sucrose in PBS (1:1) and transferred to 200-mesh grids with a carboncoated Formvar film. Grids were incubated with PBS at 37 °C for 25 min in a humid chamber. Free aldehydes were quenched with 50 mM NH 4 Cl (five times at 2 min each) before incubation with 1% BSA for 5 min. Cryosections were incubated with a rabbit CCT2-specific monoclonal antibody (Abcam, ab92746) diluted 1:20 in 1% BSA for 1 h. After washes with 0.1% BSA (5 times at 2 min each) and 1% BSA (5 min), grids were incubated for 30 min with a secondary antibody conjugated with 10 nm colloidal gold particles (BB International) diluted 1:50 in 1% BSA. Cryosections were washed with 0.1% BSA (twice at 2 min each) and PBS (3 times at 2 min each) before incubation with 1% glutaraldehyde in PBS for 5 min. After washing with water (nine times at 2 min each), grids were incubated with uranyl acetate and methylcellulose (9:1) on ice for 5 min. Grids were collected, dried, and imaged using a JEOL JEM 1011 electron microscope operating at 100 kv. Images from immunogold-labelled Tokuyasu cryosections were selected from more than 50 mock-infected and reovirus-infected cells.
High-throughput RNA interference screen. Day 1: reverse transfection of siRNA library (step 1). The Dharmacon human ON-TARGETplus druggable genome siRNA library (7,518 genes total with pools of four unique siRNAs targeting each gene) was aliquoted in triplicate into black, clear-bottom, 384-well plates (Greiner, 781091) for a final diluted siRNA concentration of 25 nM. Control siRNAs targeting JAM-A (receptor for reovirus), reovirus µ 2, reovirus μ NS and a non-targeting control were seeded into empty wells. As a control for transfection efficiency, wells also were seeded with the AllStars Cell Death control siRNA (Qiagen). Lipofectamine RNAiMax transfection reagent was diluted in Opti-MEM reduced-serum medium, and aliquoted into each well (0.07 μ l RNAiMax per well). Following a 15 min incubation at room temperature, the siRNA/lipid solution was combined with 5 × 10 2 HBMECs per well in complete RPMI medium. Cells were incubated at 37 °C for 48 h to allow efficient target knockdown.
Day 3: reovirus infection.
Previously transfected HBMECs were adsorbed with reovirus T1L M1 P208S at a MOI of 1,000 PFU per cell at 37 °C for 3 h. Cells were washed twice with PBS− /− , supplemented with complete RPMI medium, and incubated at 37 °C for 48 h. Day 6: fixation of step 2 cells. The culture medium covering step 2 cells was aspirated, and cells were incubated with ice-cold 100% methanol and stored at − 20 °C.
Day 7: immunofluorescence staining.
Step 1 and step 2 cells were brought to RT, the methanol fixative was aspirated, and cells were washed twice with PBS− /− . PBS− /− containing 5% BSA was added to each well and incubated at 37 °C for 15 min. The BSA blocking solution was aspirated, and cells were incubated with a reovirus σ NS-specific guinea pig polyclonal antiserum diluted 1:2000 in PBS− /− containing 0.5% Triton-X 100 (PBS-T) at 37 °C for 1 h. Cells were washed twice with PBS− /− and incubated with DAPI and a guinea pig-specific Alexa 488 secondary antibody (diluted 1:1000) in PBS-T at 37 °C for 1 h. Cells were wash twice with PBS− /− and covered with H 2 O for imaging. Day 8: high-content imaging. Fluorescent images were captured using an ImageXpress Micro XL (Molecular Devices) automated microscope equipped with a 20× air objective. Four independent fields of view were acquired for each well.
Day 9: quantitative image analysis. Reovirus-infected HBMECs in step 1 and step 2 plates were enumerated using MetaXpress image analysis software (Molecular Devices). Fluorescence intensity thresholds were defined to identify objects containing DAPI (total cell count) and objects containing DAPI and Alexa 488 (infected cell count). The percentage of infected cells was calculated by dividing the infected cell count by the total cell count and multiplying by 100.
Data analysis. The efficiency of reovirus release from step 1 cells and subsequent infection of step 2 cells was determined by dividing the percentage of infected cells in step 2 plates by the percentage of infected cells in step 1 plates. We termed this calculation the egress ratio. The egress ratio for each siRNA pool was transformed to a log 2 scale. Candidate genes were identified by calculating robust Z-scores using the log-transformed egress ratios. The log-transformed egress ratio values of the aggregate samples in each 384-well plate were used to calculate median and median absolute deviation values. The robust Z-scores for individual genes were then calculated using the formula below:
NATuRe MICRObIOlOgy = − . × *Robust Z score Gene egress ratio Plate egress ratio median 1 486
Plate egress ratio median absolution deviation All values are log 2 transformed in the equation above. As a viability filter, all siRNAs that reduced the step 1 cell count 2.5 standard deviations below the mean step 1 cell count for the aggregated wells in the entire screen, were removed from the analysis (102/7, 518 = 1.35% of genes). A median robust Z-score cutoff of − 2.5 was applied across the three replicates of the remaining 7,416 genes to identify candidate mediators of late steps in reovirus replication. All screening experiments were conducted in the Vanderbilt High Throughput Screening Core.
STRING protein-protein interaction prediction. STRING functional protein association network analysis 60 was conducted using the 242 candidate genes with median robust Z-scores less than or equal to − 2.5. Of the candidate genes, 241 were recognized in the analysis and assembled into an interactome map. The K means clustering algorithm was used to group the genes into four clusters.
Statistical analysis.
All experiments were performed with a minimum of three independent replicates. Data are presented as the mean ± s.e.m. unless otherwise indicated. Two-tailed unpaired Student's t-tests were used with an α = 0.05. Where indicated, ordinary one-way ANOVA analyses were performed with Tukey's multiple comparisons test (α = 0.05). For all box-and-whisker plots, whiskers denote the minimum and maximal values, boxes denote the 25th and 75th percentiles and the centre denotes the median value. Exact P-values and confidence intervals are tabulated in Supplementary Table 3 . All statistical analyses were conducted using GraphPad Prism 7.00 data analysis software.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data availability. The authors declare that the main data supporting the findings of this study are available within the article and its Supplementary Information files. Purified recombinant human TRiC is a limited resource that was provided by the Frydman Lab (Stanford University). Please contact Judith Frydman directly (jfrydman@stanford.edu) for inquiries related to purified human TRiC. 
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Experimental design 1. Sample size
Describe how sample size was determined. All experiments were performed with a minimum of three independent replicates and included a minimum of three technical replicates within each independent experiment. A sample size of three was chosen to limit experimental bias or random error. This is convention for the field of virology.
Data exclusions
Describe any data exclusions. In our RNAi screen for cellular mediators of late events in reovirus replication we applied a filter for viable cells and excluded non-viable cells from our data analysis. Non-viable cells were defined as step 1 cells with a mean cell count 2.5 standard deviations below the mean step 1 cell count for the aggregated wells in the entire screen. This was an arbitrary cut-off established before the screen was conducted.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
No randomization was used in this study. For tissue culture and in vitro work, experiments were conducted with a minimum of three technical replicates with the appropriate positive and negative controls.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was used in this study. When possible, automated machine-based methods were used for quantification to avoid observer bias. This included machine-based analysis of RNAi screen data, cell infectivity, 35S-labeled gels, and immunofluorescence images.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
